刺激
烟碱乙酰胆碱受体
内分泌学
脾脏
内科学
医学
兴奋剂
胆碱能的
乙酰胆碱受体
烟碱激动剂
乙酰胆碱
受体
免疫学
作者
Annas Al‐Sharea,Man K.S. Lee,Alexandra Whillas,Michelle Flynn,Jaye Chin‐Dusting,Andrew Murphy
标识
DOI:10.1016/j.atherosclerosis.2017.08.010
摘要
Background and aims Monocyte levels predict cardiovascular outcomes and play a causal role in atherogenesis. Monocytes can be produced in the spleen and track to the atherosclerotic lesion in significant numbers. The cholinergic system has been shown to have anti-inflammatory actions in the spleen. We aimed to explore whether therapeutic stimulation of the nicotinic acetylcholine receptor alpha 7 (nAChRα7) can suppress atherogenesis. Methods Apoe−/− mice were placed on a Western-type diet and treated with bi-daily injections of the nAChRα7 agonist GTS-21 or vehicle every 2–3 days for 8 weeks. Results GTS-21 caused a reduction in atherosclerosis in the aortic arch and proximal aorta. This also resulted in less plaque macrophages. Moreover, GTS-21 reduced the abundance of blood monocytes, which was caused by inhibition of inflammatory cytokines and extramedullary hematopoiesis in the spleen, along with splenic monocytes. Conclusions Stimulation of nAChRα7 with GTS-21 reduced atherosclerosis, which was associated with dampened splenic myelopoiesis.
科研通智能强力驱动
Strongly Powered by AbleSci AI